Skip to main content
  • Ophthalmic Pearls

    Decoding Visual Pathway Lesions

    By Madhurima A. Nayak, MS, DNB; Sagar Agarwal, MS; Samuel J. Spiegel, MD; and Sunayana Bhat, MS
    Edited by Jeremiah P. Tao, MD, FACS

    Download PDF

    Because visual information from the eye traverses the axial length of the brain to the occipital cor­tex, much ophthalmic and neurologic pathology may affect the visual path­way. By taking a systematic approach, clinicians can identify unique clinical patterns that can lead to accurate local­ization and diagnosis of visual pathway lesions.

    Anatomy of the Visual Pathway

    The afferent visual pathway begins in the retina and, as with other somato­sensory pathways, has a three-order neuronal pathway, which ultimately relays information to the occipital cortex. First-order neurons are formed by the bipolar cells of the retina, which synapse with retinal ganglion cells. These second-order neurons extend their axons along the inner­most portion of the retina, coalescing at the optic disc. These axons exit the globe and continue posteriorly via the optic nerve, and both optic nerves join in the suprasellar region to form the optic chiasm. The nasal retinal fibers (temporal visual field) decussate contralaterally, while the temporal retinal fibers (nasal visual field) remain ipsilateral. The conjoined optic nerve fibers now form the optic tracts. The optic tract axons synapse in the lateral geniculate body (LGB) of the thalamus. These, now third-order neurons, relay information from the LGB via the optic radiations (either the dorsal bundle or Meyer loop) to the visual cortex in the occipital lobe.

    Conceptualizing the visual pathway in three major sections—optic nerve, chiasm, and retrochiasm—can be help­ful in identifying patterns of disease and localization because pathology will vary based on which section of the visual pathway is affected.

    The Major Sections

    In patients with visual pathway lesions, the presenting signs and symptoms may depend on the site affected, degree of axonal loss, and amount of visual function lost. In some cases, systemic features may be associated with some of these lesions.

    Optic nerve lesions. Optic nerve pathology tends to cause symptoms of dimming or graying of vision and color desaturation, as opposed to blurring or positive visual phenomena seen in other ocular conditions. In addition, a relative afferent pupillary defect (RAPD) is typically present in unilateral or asymmetric bilateral optic nerve pathology.

    The most anterior portion, the intra­orbital segment of the optic disc, has a separate vascular supply, making it par­ticularly susceptible to ischemic dam­age, which may translate to defects on exam, visual fields, and OCT findings that respect the horizontal meridian.

    Intracanalicular and intracranial portions of the optic nerve may have other associated focal neurologic defi­cits/cranial neuropathies (e.g., orbital apex syndrome) to help with further lo­calization. Examples of common condi­tions are listed with associated clinical and imaging features in Table 1. A wide array of pathology may affect the optic nerve, including ischemic, compressive, inflammatory, or infiltrative processes. Common conditions include optic neu­ritis, ischemic optic neuropathy (arte­ritic and nonarteritic), infiltrative optic neuropathies (leukemia, lymphoma, sarcoid), infectious optic neuropathy (syphilis, tuberculosis, Lyme disease), traumatic optic neuropathy, compres­sive optic neuropathy, and hereditary and toxic optic neuropathies.

    Papilledema is bilateral, passive, disc swelling as a result of raised intracrani­al pressure and not a lesion of the visual pathway. But, since it presents as disc swelling and can mimic optic nerve lesions, it is being discussed here.

    Chiasmal lesions. Chiasmal syn­drome classically presents with bilateral heteronymous field defects.1 The optic chiasm is prone to compression given its suprasellar location. Inferior com­pression of the chiasm is most typical, but it also can be compressed anteri­orly, centrally, laterally, posteriorly, or superiorly. Most commonly, pituitary adenomas are the cause of chiasmal syndrome, but craniopharyngioma and meningiomas are also somewhat common. Intrinsic infectious, inflam­matory, and infiltrative lesions should also be considered (e.g., chiasmitis as a presenting sign of neuromyelitis optica spectrum disorder).2 Table 2 outlines identifying characteristics of various types of compression.

    Retrochiasmal lesions. All lesions that affect the visual pathway poste­rior to the chiasm are characterized by contralateral homonymous field defects. Generally, the congruity of field defects increases with a more posterior location of the lesion.

    Retrochiasmal lesions may or may not be accompanied by an RAPD. Lesions of the optic tract can have an RAPD, as there is an asymmetric cross­ing of fibers at the optic chiasm. How­ever, fibers involved in the pupillary reflex exit the optic tract just prior to the LGB; therefore lesions at, or distal, to the LGB should not have an RAPD.

    Common causes of retrochiasmal lesions are metastatic tumors, primary central nervous system tumors, trauma, demyelinating disease, vascular injury (ischemic/hemorrhagic infarct).3 Table 3 covers lesions of the optic tract, LGB, and optic radiations.

    Testing and Management

    Testing. Although visual field analysis usually is sufficient for localizing a visu­al pathway lesion, ancillary testing or imaging can be helpful. OCT provides an added advantage in the three following situations: 1) When the patient is unable to perform a visual field analysis due to poor vision or limited under­standing or comprehension; 2) when objective measurement of axonal loss is desired; 3) when prognostication of recovery is desired. OCT analysis of peripapillary retinal nerve fiber layer (ppRNFL) thickness and macular gan­glion cell–inner plexiform layer (GCI­PL) thickness provides clinicians with objective data that can aid in diagnosis and monitoring of neuro-ophthalmic conditions. Additionally, GCIPL has shown increased sensitivity in the de­tection of early compressive lesions.

    Management. The underlying cause for a visual pathway lesion may be established through examination, imaging, or lab testing. Treatment depends on the etiology and may require a multi­disciplinary approach.

    Conclusion

    Lesions can affect any portion of the visual pathway, and they may have a characteristic presentation. A complete ophthalmic exam, with emphasis on disc appearance, visual field defects, and pattern of nerve fiber loss on OCT helps in localizing the lesion. When visual field analysis cannot be per­formed, the pattern of ppRNFL and GCIPL thinning on OCT can serve as an adjunct.

    ___________________________

    1 Astorga-Carballo A et al. Saudi J Ophthalmol. 2017;31(4):229-233.

    2 Rui W et al. J Neuroophthal. 2019;39(4):515-515.

    3 Fadzli F et al. Clin Radiol. 2013;68(10):e538-e551.

    4 Papchenko T et al. Acta Ophthalmol. 2012;90(6):e463-e469.

    5 Noval S et al. Mult Scler Int. 2011;2011:472790.

    6 Bennett JL et al. Mult Scler. 2015;21(6):678-688.

    7 Lloyd-Smith AJ et al. Neurology. 2016;87(19):2063-2064.

    8 Yamashita T et al. J Ophthalmol. 2016;2016:2394957.

    ___________________________

    Dr. Agarwal is senior ophthalmologist, Sparsh Eye Hospital, Bareilly, India. Dr. Bhat is associate professor and Dr. Nayak is assistant professor of ophthalmology, Father Muller Medical College, Mangaluru, India. Dr. Spiegel is assistant clinical professor of ophthalmology, University of Cali­fornia Irvine. Financial disclosures: None.